Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melacine plus Interferon vs Interferon in Metastatic Melanoma
NCT00002767Phase 3Unknown
- Sponsor
- GSK
- Start
- Jan 1996
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Melacine in melanoma, sponsored by GSK. Status: unknown.
02
Drugs
Melacine
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002767.